← Open Payments lookup

ADA ARIZMENDI: Open Payments

NPI 1043789860 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$734 in 24 payments from 11 companies in 2025. Trend: 2023 $3,755 · 2024 $1,275 · 2025 $734

Food & beverage: $734
CompanyPaymentsAmount
ABBVIE INC.12$291
Takeda Pharmaceuticals U.S.A., Inc.2$237
Janssen Biotech, Inc.2$44
PFIZER INC.1$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Phathom Pharmaceuticals, Inc.1$22
VIVUS LLC1$20
Ardelyx, Inc.1$19
GENZYME CORPORATION1$18
Braintree Laboratories, Inc.1$17

Products named: ENTYVIO, SKYRIZI, LINZESS, TREMFYA, CREON, VELSIPITY, MAVYRET, XIFAXAN.

Industry payments across FL — which companies pay providers there.